Indian Economy News

Novartis Expands India Role in Global Drug Development

Global pharmaceutical company Novartis is strengthening India’s role in its global drug development and innovation strategy by expanding research, development and clinical operations across the country. According to the company, India has emerged as a key hub for scientific talent, digital capabilities and advanced research support, enabling greater participation in global pharmaceutical innovation and drug discovery programmes. Novartis currently employs a large workforce of scientists, data specialists and technology professionals in India who support multiple stages of the global drug development lifecycle, including clinical research, data analytics, artificial intelligence (AI)-enabled research and regulatory operations. The company stated that India’s strong talent ecosystem and expanding digital infrastructure are playing a critical role in accelerating pharmaceutical innovation and improving healthcare outcomes globally.

Novartis also highlighted that India is becoming increasingly important for advanced capability centres supporting global operations in areas such as biomedical research, AI-driven drug discovery, automation and digital healthcare technologies. Industry experts noted that multinational pharmaceutical companies are expanding R&D operations in India due to the country’s skilled workforce, cost competitiveness and growing expertise in biotechnology and life sciences. The expansion aligns with India’s broader objective of strengthening its pharmaceutical research ecosystem, promoting innovation-led healthcare growth and enhancing its position in the global biopharmaceutical value chain. The continued growth of global capability centres and research operations in India reflects increasing international confidence in the country’s scientific and technology-driven healthcare ecosystem.

Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.